Publicidad
Referencias
Price D, Walker T. The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive
Continuous Glucose Monitoring Use. Eur Endocrinol. 2016;12(1):24-30. doi:10.17925/EE.2016.12.01.24
Beck, R (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin
injections: the DIAMOND randomized clinical trial. JAMA, 317(4):371-378. doi:10.1001/jama.2016.19975
The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the
development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 329:977-986.
Lind, M (2017). Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes
treated with multiple daily insulin injections: the gold randomized clinical trial. JAMA, 317(4):379-387.
doi:10.1001/jama.2016.19976.
Pettus, J (2015). How patients with type 1 diabetes translate continuous glucose monitoring data into diabetes management
decisions. Endocr Pract, 21(6):613-620. doi: 10.4158/EP14520.OR.
Polonsky WH and Fortmann AL. Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health
Outcomes in Adults with Type 1 Diabetes. Diabetes Technol Ther 2020. doi: 10.1089/dia.2020.0466.
Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a factory-calibrated, real-time continuous glucose monitoring system
during 10 days of use in youth and adults with diabetes. Diabetes Technol Ther. 2018;20(6):395-402.
2 • Información de seguridad |
Guía del usuario del Dexcom ONE+
10
Publicidad
